Printer Friendly

BRISTOL-MYERS SQUIBB COMPANY PROMOTES SPECIALTY PHARMACEUTICALS EXECUTIVE

 PRINCETON, N.J., March 26 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that Andrew G. Bodnar, M.D., J.D., has been promoted to president, Specialty Pharmaceuticals.
 Bodnar will oversee Bristol-Myers Squibb Company's four specialty pharmaceutical businesses -- Bristol-Myers Squibb Oncology Division, Westwood-Squibb, Mead Johnson Laboratories and Squibb Diagnostics. He also will be responsible for worldwide Strategic Product Planning for the company's Diagnostics and Oncology franchises.
 Since joining Bristol-Myers Squibb Company in 1989, Bodnar has played an important role in the formation of the Pharmaceutical Group. He joined as senior vice president and chief operating officer of The Squibb Institute for Medical Research and later was acting president of the Bristol-Myers Squibb Pharmaceutical Research Institute. Most recently, Bodnar served as senior vice president, Strategic Management, Bristol-Myers Squibb Pharmaceutical Group.
 Bodnar received his A.B. (magna cum laude) from Harvard College, his M.D. from the Columbia College of Physicians and Surgeons, and his J.D. (magna cum laude) from Harvard Law School. He is a resident of Princeton.
 /delval/
 -0- 3/26/93
 /CONTACT: Patrick Donohue of Bristol-Myers Squibb, 609-252-5685/
 (BMY)


CO: Bristol-Myers Squibb ST: New Jersey IN: MTC SU: PER

MK-CC -- PH001 -- 9921 03/26/93 07:52 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 26, 1993
Words:200
Previous Article:HOUSTON LIGHTING & POWER OFFERS TO PURCHASE BONDS
Next Article:KAISER ALUMINUM OMITS COMMON STOCK DIVIDEND
Topics:


Related Articles
CYTOGEN WELCOMES MARY BEALS AS DIRECTOR OF CORPORATE COMMUNICATIONS
BRISTOL-MYERS SQUIBB ANNOUNCES PROMOTION OF E. LYNN JOHNSON
BRISTOL-MYERS SQUIBB PROMOTES WEG TO GROUP PRESIDENT
BRISTOL-MYERS SQUIBB EXECUTIVE ASSUMES ADDITIONAL COMPANY RESPONSIBILITY
BRISTOL-MYERS SQUIBB PHARMACEUTICAL
DR. SHARON HENRY OF BRISTOL-MYERS SQUIBB COMPANY RECEIVES HEALTH WATCH'S FIRST WOMEN'S LEADERSHIP AWARD
BRISTOL-MYERS SQUIBB COMPANY PROMOTES LEGAL EXECUTIVE
SIX STUDENTS SELECTED AS PHARMACEUTICAL INDUSTRY INTERNS AT BRISTOL-MYERS SQUIBB COMPANY
BRISTOL-MYERS SQUIBB ANNOUNCES TWO EXECUTIVE CHANGES
BRISTOL-MYERS SQUIBB ANNOUNCES NEW ORGANIZATION FOR CONSUMER BUSINESSES; TWO WORLDWIDE BUSINESS UNITS CREATED

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters